[go: up one dir, main page]

WO2003102209A3 - Isoformes alternativement episses de la hmg co-a reductase humaine - Google Patents

Isoformes alternativement episses de la hmg co-a reductase humaine Download PDF

Info

Publication number
WO2003102209A3
WO2003102209A3 PCT/US2003/016337 US0316337W WO03102209A3 WO 2003102209 A3 WO2003102209 A3 WO 2003102209A3 US 0316337 W US0316337 W US 0316337W WO 03102209 A3 WO03102209 A3 WO 03102209A3
Authority
WO
WIPO (PCT)
Prior art keywords
seq
hmgcrsv4
hmgcrsv3
hmgcrsv2
hmgcrsv1
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US2003/016337
Other languages
English (en)
Other versions
WO2003102209A2 (fr
Inventor
Jason M Johnson
Christopher D Armour
John C Castle
Philip W Garrett-Engele
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Rosetta Inpharmatics LLC
Original Assignee
Rosetta Inpharmatics LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rosetta Inpharmatics LLC filed Critical Rosetta Inpharmatics LLC
Publication of WO2003102209A2 publication Critical patent/WO2003102209A2/fr
Publication of WO2003102209A3 publication Critical patent/WO2003102209A3/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004—Oxidoreductases (1.)

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Enzymes And Modification Thereof (AREA)

Abstract

L'invention concerne des acides nucléiques et des polypeptides codant des nouveaux isoformes de variant d'épissage de 3-hydroxy-3-méthylglutaryle-CoA réductase (HMGCR). Les séquences polynucléotidiques des isoformes HMGCRsv1, HMGCRsv2, HMGCRsv3, et HMGCRsv4 sont respectivement représentées par SEQ ID NO 1, SEQ ID NO 3, SEQ ID NO 5, et SEQ ID NO 7. Les séquences d'acides aminés pour les isoformes HMGCRsv1, HMGCRsv2, HMGCRsv3, et HMGCRsv4 sont respectivement représentées par SEQ ID NO 2, SEQ ID NO 4, SEQ ID NO 6, et SEQ ID NO 8. L'invention concerne également des procédés d'utilisation des polynucléotides et des protéines des isoformes HMGCRsv1, HMGCRsv2, HMGCRsv3, et HMGCRsv4 afin de cribler des composés qui se lient respectivement aux isoformes HMGCRsv1, HMGCRsv2, HMGCRsv3, et HMGCRsv4.
PCT/US2003/016337 2002-05-30 2003-05-23 Isoformes alternativement episses de la hmg co-a reductase humaine Ceased WO2003102209A2 (fr)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US38518802P 2002-05-30 2002-05-30
US60/385,188 2002-05-30
US40715502P 2002-08-29 2002-08-29
US60/407,155 2002-08-29

Publications (2)

Publication Number Publication Date
WO2003102209A2 WO2003102209A2 (fr) 2003-12-11
WO2003102209A3 true WO2003102209A3 (fr) 2004-11-04

Family

ID=29715360

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2003/016337 Ceased WO2003102209A2 (fr) 2002-05-30 2003-05-23 Isoformes alternativement episses de la hmg co-a reductase humaine

Country Status (1)

Country Link
WO (1) WO2003102209A2 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8084209B2 (en) 2005-07-22 2011-12-27 Children's Hospital & Research Center Oakland HMGCR isoforms in prediction of efficacy and identification of cholesterol-modulating compounds
CN108220375A (zh) * 2018-02-10 2018-06-29 海盐县凌特生物科技有限公司 以蚕蛹为原料制备的降血脂功能肽

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
BASSON M.E. ET AL: "Structural and functional conservation between yeast and human 3-hydroxy-3-methylglutaryl coenzyme A reductases, the rate-limiting enzyme of sterol biosynthesis", MOLECULAR AND CELLULAR BIOLOGY, vol. 8, no. 9, September 1988 (1988-09-01), pages 3797 - 3808, XP002981008 *
DATABASE GENBANK [online] 9 July 2002 (2002-07-09), STRAUSBERG R.L. ET AL: "Homo sapiens 3-hydroxy-3-methylglutaryl-Coenzyme A reductase, mRNA (cDNA clone MGC:45281 IMAGE:5212903), complete cds.", XP002981006, Database accession no. BC033692 *
LUSKEY K.L. AND STEVENS B.: "Human 3-hydroxy-3-methylglutaryl coenzyme A reductase. Conserved domains responsible for catalytic activity and sterol-regulated degradation", JOURNAL OF BIOLOGICAL CHEMISTRY, vol. 260, no. 18, 25 August 1985 (1985-08-25), pages 10271 - 10277, XP002981007 *

Also Published As

Publication number Publication date
WO2003102209A2 (fr) 2003-12-11

Similar Documents

Publication Publication Date Title
WO2003102132A3 (fr) Purification de proteines basee sur la non affinite
EP0832973A3 (fr) Protéine de liaison de GTP
WO2001005950A3 (fr) Nouveaux procedes permettant la presentation de (poly)peptides/proteines sur des particules bacteriophages au moyen de liaisons disulfure
WO2004078777A3 (fr) Proteines protegees contre la dipeptidylpeptidase
WO2003020932A1 (fr) Nouvelles proteines de secretion et adn associe
WO2002002627A3 (fr) Proteine zcyto21de type interferon
WO2004083234A3 (fr) Conjugues polypeptide insulinique-oligomere, conjugues polypeptide proinsulinique-oligomere, et procedes de synthese correspondants
WO2002008767A3 (fr) Nouveaux procedes et trousses de sequençage de polypeptides
WO2003022996A3 (fr) Synthese de conjugues polypeptides-oligomeres de l'insuline, et conjugues polypeptides-oligomeres de proinsuline, et modalites de leur synthese
EP0897011A3 (fr) Arginine deiminase
WO2003002730A3 (fr) Methode de detection de l'activite de la calpaine 3 dans un echantillon biologique et peptides pour la mise en oeuvre de ladite methode
WO2004039834A3 (fr) Variants de proteines de recombinaison
WO2003102209A3 (fr) Isoformes alternativement episses de la hmg co-a reductase humaine
WO2000058465A3 (fr) Analogues polypeptidiques de flint
WO2002008257A3 (fr) Nouveaux siglecs et leurs utilisations
EP0832978A3 (fr) 3-Déhydroquinate synthase
EP0911409A3 (fr) Deformylase
EP0801132A3 (fr) Protéine FtsH des staphylocoques
EP0927763A3 (fr) Nouvelle aroA
WO2004007536A3 (fr) Nouvelles interactions de la proteine du virus d'epstein-barr ebna1, compositions et methodes associees
WO2003004678A3 (fr) Nouveaux recepteurs
EP0897008A3 (fr) His5
AU2003226907A1 (en) Method for the preparation of recombinant mammalian heparin-binding protein (hbp)
WO2000058472A3 (fr) Adn isole codant pour des regulateurs cullin roc1 et roc2, proteines isolees codees par ledit adn. procedes d'utilisation associes
EP0905249A3 (fr) Déhydrogénase d'alcool

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): CA JP US

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT RO SE SI SK TR

121 Ep: the epo has been informed by wipo that ep was designated in this application
122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Country of ref document: JP